[go: up one dir, main page]

AR028122A1 - Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones - Google Patents

Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones

Info

Publication number
AR028122A1
AR028122A1 ARP010102577A ARP010102577A AR028122A1 AR 028122 A1 AR028122 A1 AR 028122A1 AR P010102577 A ARP010102577 A AR P010102577A AR P010102577 A ARP010102577 A AR P010102577A AR 028122 A1 AR028122 A1 AR 028122A1
Authority
AR
Argentina
Prior art keywords
aminotiolester
pharmaceutical
compounds
contain
new
Prior art date
Application number
ARP010102577A
Other languages
English (en)
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of AR028122A1 publication Critical patent/AR028122A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/22Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP010102577A 2000-05-31 2001-05-30 Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones AR028122A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007029A FR2809727B1 (fr) 2000-05-31 2000-05-31 Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations

Publications (1)

Publication Number Publication Date
AR028122A1 true AR028122A1 (es) 2003-04-23

Family

ID=8850863

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102577A AR028122A1 (es) 2000-05-31 2001-05-30 Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones

Country Status (10)

Country Link
US (1) US8026231B2 (es)
EP (1) EP1296946B1 (es)
JP (1) JP4855626B2 (es)
AR (1) AR028122A1 (es)
AT (1) ATE264839T1 (es)
AU (1) AU2001274171A1 (es)
DE (1) DE60102925T2 (es)
ES (1) ES2219530T3 (es)
FR (1) FR2809727B1 (es)
WO (1) WO2001092220A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2983492B1 (fr) * 2011-12-06 2015-10-30 Advanced Biodesign Procede ex vivo de purge tumorale d'un echantillon biologique
AR106352A1 (es) * 2015-10-15 2018-01-03 Advanced Biodesign Compuestos de aminotioléster o las sales farmacéuticamente aceptables del mismo, para usar en el tratamiento del cáncer
JP7062592B2 (ja) * 2015-10-15 2022-05-06 アドヴァンスト・バイオデザイン アミノチオールエステル化合物またはその薬学的に許容される塩および対象の癌細胞におけるh2o2濃度を増大し得る化合物の組み合わせ
FR3047734B1 (fr) * 2016-02-17 2019-09-06 Advanced Biodesign Procede de preparation de composes aminothiolester et leurs sels
JP7681566B2 (ja) * 2019-07-31 2025-05-22 アドヴァンスト・バイオデザイン アミノチオールエステル化合物及びその使用
FR3119314B1 (fr) 2021-01-29 2025-01-10 Advanced Biodesign Nanocapsule lipidique comprenant au moins un composé aminothiolester ou un de ses dérivés pharmaceutiquement acceptable
EP4035666A1 (en) 2021-01-29 2022-08-03 Advanced Biodesign Aminothiolester compound or derivative thereof for use as an immunomodulatory agent
WO2025229179A1 (en) 2024-05-03 2025-11-06 Advanced Biodesign Use of aminothiolester compounds in combination with hypomethylating agents (hma) for the prevention and treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051528A (en) * 1990-04-24 1991-09-24 Eastman Kodak Company Recovery process for ethylene glycol and dimethylterephthalate
JPH0797350A (ja) * 1993-08-02 1995-04-11 Mitsubishi Chem Corp ベンゾイルアセチレン誘導体
FR2761606B1 (fr) * 1997-04-08 1999-05-14 Cird Galderma Utilisation de derives aminothiolesters dans le domaine pharmaceutique
CA2279892C (en) 1997-12-02 2008-02-12 Heinrich Smuda Method of recovery of terephthalic acid and ethylene glycol from poly/ethylene terephthalate/wastes
FR2777001B1 (fr) * 1998-04-01 2000-06-09 Cird Galderma Derives de l'acide 6,8-dimercaptooctanoique substitues en 6-s et/ou en 8-s par le radical (3-methylthiopropanoyl) et compositions pharmaceutiques destinees au traitement des tumeurs cancereuses
JP4067306B2 (ja) 1999-10-22 2008-03-26 帝人ファイバー株式会社 ポリエステル廃棄物からテレフタル酸ジメチル及びエチレングリコールを分離回収する方法
JP3808672B2 (ja) * 1999-11-26 2006-08-16 東洋製罐株式会社 回収ポリエチレンテレフタレート粉砕品からのテレフタル酸の工業的回収方法

Also Published As

Publication number Publication date
WO2001092220A1 (fr) 2001-12-06
ES2219530T3 (es) 2004-12-01
JP2003535076A (ja) 2003-11-25
JP4855626B2 (ja) 2012-01-18
US20070032476A1 (en) 2007-02-08
FR2809727A1 (fr) 2001-12-07
AU2001274171A1 (en) 2001-12-11
FR2809727B1 (fr) 2002-07-26
EP1296946A1 (fr) 2003-04-02
ATE264839T1 (de) 2004-05-15
EP1296946B1 (fr) 2004-04-21
DE60102925D1 (de) 2004-05-27
DE60102925T2 (de) 2005-04-07
US8026231B2 (en) 2011-09-27

Similar Documents

Publication Publication Date Title
NO20025450L (no) Ny farmasöytisk sammensetning
FR2795324B1 (fr) Compositions pharmaceutiques stabilisees
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
ITMI20010748A0 (it) Composizioni farmaceutiche
DK1524266T3 (da) Farmaceutisk sammensætning
ITTO20010008A0 (it) Formulazione farmaceutica
FR2824267B1 (fr) Composition cosmetique filmogene
AR027998A1 (es) Derivados de etilendiamina y los medicamentos y composiciones farmaceuticas que los contienen
AR028087A1 (es) Composiciones cosmeticas
ITMI991754A0 (it) Composizioni cosmetiche
EE05020B1 (et) Glburiidi ravimkoostis
FR2810237B1 (fr) Composition cosmetique filmogene
FR2810238B1 (fr) Composition cosmetique filmogene
NO20026123L (no) Farmasöytiske sammensetninger
FR2814673B1 (fr) Composition cosmetique filmogene
FR2810236B1 (fr) Composition cosmetique filmogene
FR2810239B1 (fr) Composition cosmetique filmogene
DE60111988D1 (de) Kosmetische Zusammensetzung
ATE366128T1 (de) Pharmazeutische zusammensetzung
DE60139896D1 (de) Ldenden zusammensetzungen
AR027959A1 (es) Composiciones cosmeticas
AR028122A1 (es) Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones
PT986537E (pt) Novos compostos heteroetinilenos e composicoes farmaceuticas e cosmeticas contendo-os
DE60008839D1 (de) Duftstoff-Zusammensetzung

Legal Events

Date Code Title Description
FB Suspension of granting procedure